33598364|t|Movement Disorders and Dementia in a Woman With Chronic Aluminium Toxicity: Video-MRI Imaging.
33598364|a|Background: Aluminium encephalopathy results from exposure to aluminium from occupational, recreational, and environmental sources. Movement disorders, cerebellar ataxia, pyramidal tract signs, dementia, microcytic anemia and bone disease are typical manifestations. Case Report: A 55-year-old woman had clinical manifestations, persistent hyperaluminemia without magnetic resonance imaging (MRI) scan changes of toxic encephalopathy following a prolonged exposure to marine grade paints containing 30% aluminium. Chelation therapy with ethylenediaminetetraacetic acid (EDTA) demonstrated decreased levels of aluminemia and significant neurological improvement over time. Discussion: This diagnosis should be entertained in patients with movement disorders, cerebellar ataxia, pyramidal signs, and dementia of unknown etiology. Highlights: Aluminium encephalopathy (AE) is a neurological syndrome caused by aluminium neurotoxicity. Manifestations include cognitive impairment, motor dysfunction, microcytic anemia and bone disease. This case illustrates AE with hyperaluminemia associated with chronic exposure to industrial paints and clinical and biochemical reversibility after chelation therapy with ethylenediaminetetraacetic acid. Movement disorders are highlighted.
33598364	0	18	Movement Disorders	Disease	MESH:D009069
33598364	23	31	Dementia	Disease	MESH:D003704
33598364	37	42	Woman	Species	9606
33598364	56	65	Aluminium	Chemical	MESH:D000535
33598364	66	74	Toxicity	Disease	MESH:D064420
33598364	107	131	Aluminium encephalopathy	Chemical	-
33598364	157	166	aluminium	Chemical	MESH:D000535
33598364	227	245	Movement disorders	Disease	MESH:D009069
33598364	247	264	cerebellar ataxia	Disease	MESH:D002524
33598364	289	297	dementia	Disease	MESH:D003704
33598364	299	316	microcytic anemia	Disease	MESH:C536357
33598364	321	333	bone disease	Disease	MESH:D001847
33598364	389	394	woman	Species	9606
33598364	435	450	hyperaluminemia	Disease	
33598364	508	528	toxic encephalopathy	Disease	MESH:D020258
33598364	598	607	aluminium	Chemical	MESH:D000535
33598364	632	663	ethylenediaminetetraacetic acid	Chemical	MESH:D004492
33598364	665	669	EDTA	Chemical	MESH:D004492
33598364	704	714	aluminemia	Disease	
33598364	819	827	patients	Species	9606
33598364	833	851	movement disorders	Disease	MESH:D009069
33598364	853	870	cerebellar ataxia	Disease	MESH:D002524
33598364	872	887	pyramidal signs	Disease	MESH:D015419
33598364	893	901	dementia	Disease	MESH:D003704
33598364	935	959	Aluminium encephalopathy	Disease	MESH:D001927
33598364	961	963	AE	Disease	MESH:D001927
33598364	970	991	neurological syndrome	Disease	MESH:D009461
33598364	1002	1025	aluminium neurotoxicity	Chemical	-
33598364	1050	1070	cognitive impairment	Disease	MESH:D003072
33598364	1072	1089	motor dysfunction	Disease	MESH:D000068079
33598364	1091	1108	microcytic anemia	Disease	MESH:C536357
33598364	1113	1125	bone disease	Disease	MESH:D001847
33598364	1149	1151	AE	Disease	MESH:D001927
33598364	1157	1172	hyperaluminemia	Disease	
33598364	1299	1330	ethylenediaminetetraacetic acid	Chemical	MESH:D004492
33598364	1332	1350	Movement disorders	Disease	MESH:D009069
33598364	Positive_Correlation	MESH:D000535	MESH:D020258
33598364	Negative_Correlation	MESH:D004492	MESH:D020258
33598364	Negative_Correlation	MESH:D004492	MESH:D001927
33598364	Positive_Correlation	MESH:D000535	MESH:D003704
33598364	Negative_Correlation	MESH:D000535	MESH:D004492

